Things are looking up for these drug companies as they make progress with the FDA

Even if biotech companies like TG Therapeutics and Clovis Oncology don’t get bought out, they’re still attractive on a standalone basis.

Cramer got his first vaccine shot, and he's enthusiastic about the innovative technology and science that will fuel economic and human recovery.

Silver Spike Acquisition, Immutep, 8x8, TG Therapeutics and TechTarget are five of the top stock gainers on Thursday.

TG Therapeutics soars after the biopharma reports positive test results for its multiple sclerosis treatment.

Some stocks that will work under a Trump administration also will work in a Biden portfolio, says Jim Cramer. He looks at which sectors and industries are poised to profit -- and which aren't.

As we leap into earnings season, Jim Cramer look at profits, trade, employment, inflation and whether this rally is worth the risk. Here's your game plan for next week.

Jim Cramer says we need to bake in as much bad news as possible before the market really finds a bottom. There will be more declines ahead.

It's the right amount of growth and wage gains, says Jim Cramer. And here's your game plan for next week.

Tesla's billionaire CEO is calling on the Biden administration to make a move against the mass incarceration of people for weed.

Stocks finished the day mixed as investors reappraised inflation concerns and the potential impact on interest rates.

Royal Caribbean cruise line has slowly returned to its prepandemic normal, and Carnival Cruise is likely to follow on soon.